Investigating glatiramer acetate for relapsing–remitting multiple sclerosis at the double dose—is more better?

被引：0
|
作者：
Peter A Calabresi
机构：
[1] PA Calabresi is Associate Professor of Neurology and Director of the Johns Hopkins Multiple Sclerosis Center,
[2] Baltimore,undefined
[3] MD,undefined
[4] USA.,undefined
来源：
Nature Clinical Practice Neurology | 2007年 / 3卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：540 / 541
页数：1
相关论文
共 50 条
  • [31] Fatigue in relapsing-remitting multiple sclerosis patients using glatiramer acetate - FOCUS Study
    Jongen, PJH
    Carton, H
    Sanders, EACM
    Seeldrayers, P
    Fredrikson, S
    Andersson, M
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S257 - S257
  • [32] Gene Expression Biomarkers for Glatiramer Acetate Treatment Response in Relapsing-Remitting Multiple Sclerosis
    Anis, Saar
    Sonis, Polina
    Hanael, Erez
    Gurevich, Michael
    Achiron, Anat
    [J]. NEUROLOGY, 2013, 80
  • [33] Glatiramer acetate induced gene expression regulatory networks in relapsing-remitting multiple sclerosis
    Achiron, A
    Snir, Y
    Feldman, A
    Gurevich, M
    [J]. NEUROLOGY, 2006, 66 (05) : A370 - A370
  • [34] Glatiramer acetate following mitoxantrone induction in relapsing-remitting multiple sclerosis: extended experience
    Ramtahal, Jason
    Boggild, Mike
    [J]. MULTIPLE SCLEROSIS, 2008, 14 : S175 - S175
  • [35] Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis
    Kalincik, Tomas
    Jokubaitis, Vilija
    Izquierdo, Guillermo
    Duquette, Pierre
    Girard, Marc
    Grammond, Pierre
    Lugaresi, Alessandra
    Oreja-Guevara, Celia
    Bergamaschi, Roberto
    Hupperts, Raymond
    Grand'Maison, Francois
    Pucci, Eugenio
    Van Pesch, Vincent
    Boz, Cavit
    Iuliano, Gerardo
    Fernandez-Bolanos, Ricardo
    Flechter, Shlomo
    Spitaleri, Daniele
    Cristiano, Edgardo
    Verheul, Freek
    Lechner-Scott, Jeannette
    Amato, Maria Pia
    Antonio Cabrera-Gomez, Jose
    Saladino, Maria Laura
    Slee, Mark
    Moore, Fraser
    Gray, Orla
    Paine, Mark
    Barnett, Michael
    Havrdova, Eva
    Horakova, Dana
    Spelman, Timothy
    Trojano, Maria
    Butzkueven, Helmut
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (09) : 1159 - 1171
  • [36] Is glatiramer acetate better for pregnancy in multiple sclerosis?
    Kasatkin, D. S.
    Vinogradova, T. V.
    Shitova, A. S.
    Spirin, N. N.
    [J]. JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E307 - E308
  • [37] Glatiramer Acetate A Review of its Use in Relapsing-Remitting Multiple Sclerosis and in Delaying the Onset of Clinically Definite Multiple Sclerosis
    Carter, Natalie J.
    Keating, Gillian M.
    [J]. DRUGS, 2010, 70 (12) : 1545 - 1577
  • [38] Comparing the effect of glatiramer acetate 20 mg vs glatiramer acetate 40 mg on retinal structures in patients with relapsing remitting multiple sclerosis
    Gilroy, M.
    Darling, R.
    Lichtman-Mikol, S.
    Razmjou, S.
    Probst-Simmons, E.
    Santiago-Martinez, C.
    Bernitsas, E.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 647 - 648
  • [39] Effect of glatiramer acetate on cerebral grey matter pathology in patients with relapsing-remitting multiple sclerosis
    Crescenzo, F.
    Marastoni, D.
    Zuco, C.
    Pitteri, M.
    Magliozzi, R.
    Monaco, S.
    Calabrese, M.
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 27 : 305 - 311
  • [40] A combination trial of estriol plus glatiramer acetate in relapsing-remitting multiple sclerosis: effect on disabilities
    Voskuhl, R.
    Wang, H.
    Lee, G.
    Giesser, B.
    Tse, C. H.
    Elashoff, R.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2014, 20 : 44 - 44
12345